|1.||Nakamura, Tatsufumi: 2 articles (01/2013 - 01/2009)|
|2.||Nishiura, Yoshihiro: 2 articles (01/2013 - 01/2009)|
|3.||Nakamura, Hideki: 2 articles (01/2013 - 01/2009)|
|4.||Yamato, Shinji: 1 article (01/2013)|
|5.||Kinoshita, Ikuo: 1 article (01/2013)|
|6.||Narita-Masuda, Tomoko: 1 article (01/2013)|
|7.||Sakai, Hideki: 1 article (01/2013)|
|8.||Yamaguchi, Kentaro: 1 article (01/2013)|
|9.||Kawakami, Atsushi: 1 article (01/2013)|
|10.||Kira, Jun-Ichi: 1 article (01/2013)|
|1.||Tropical Spastic Paraparesis (Tropical Spastic Paraplegia)
01/01/2013 - "Based on the finding that prosultiamine induces apoptosis in human T lymphotropic virus type I (HTLV-I)-infected T cells, Nakamura et al. conducted a clinical trial of prosultiamine in patients with HTLV-I-associated myelopathy (HAM)/tropical spastic paraparesis (TSP). "
01/01/2013 - "Efficacy of prosultiamine treatment in patients with human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis: results from an open-label clinical trial."
01/01/2009 - "This study was conducted to construct a basis for a therapeutic strategy against human T-lymphotropic virus type-I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) using a compound that contained a disulfide moiety, prosultiamine, which is a homologue of allithiamine originally synthesized by allicin and thiamine-thiol, for the targeting of HTLV-I-infected cells. "
|2.||Spinal Cord Diseases
|3.||Respiratory Tract Infections (Respiratory Tract Infection)
03/01/2009 - "[Effect of Alinamin F and Kakkontou on mucoid Pseudomonas aeruginosa chronic lower respiratory tract infection]."
03/01/2009 - "In a 78-year-old woman with chronic respiratory tract infection caused by Pseudomonas aeruginosa with a mucoid phenotype, the organism was eliminated from the sputum by use of Kakkontou (Chinese herbal drug) and Alinamin F (Fursultiamine). "
|6.||dimethyl sulfone (methylsulfonylmethane)